Literature DB >> 20856629

Preventing venous thromboembolism in cancer patients: can we do better?

Gary H Lyman.   

Abstract

Entities:  

Year:  2009        PMID： 20856629      PMCID： PMC2795417          DOI： 10.1200/JOP.0941501

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  18 in total

1.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

Review 2.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Authors:  Helen K Chew; Theodore Wun; Danielle Harvey; Hong Zhou; Richard H White
Journal:  Arch Intern Med       Date:  2006-02-27

4.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors:  M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

5.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  Venous thrombosis in cancer patients: insights from the FRONTLINE survey.

Authors:  Ajay K Kakkar; Mark Levine; H M Pinedo; Robert Wolff; John Wong
Journal:  Oncologist       Date:  2003

7.  Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Authors:  Alain Leizorovicz; Alexander T Cohen; Alexander G G Turpie; Carl-Gustav Olsson; Paul T Vaitkus; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

8.  Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?

Authors:  V S Shen; E W Pollak
Journal:  South Med J       Date:  1980-07       Impact factor: 0.954

9.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Causes of death in cancer patients.

Authors:  J L Ambrus; C M Ambrus; I B Mink; J W Pickren
Journal:  J Med       Date:  1975
View more
  1 in total

1.  A Prospective Observational Study to Determine Rate of Thromboprophylaxis in Oncology Patients Undergoing Abdominal or Pelvic Surgery.

Authors:  Shailesh V Shrikhande; Manish Verma
Journal:  Indian J Surg Oncol       Date:  2021-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.